Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLYCD | O95822 | 5/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.44 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18910372 | 0.97 | MLYCD (0.46) | MLYCDCYP2D6HDAC6HDAC1HDAC8 | |
| SCHEMBL17623817 | 0.90 | HDAC6 (0.45) | MLYCDHDAC6HDAC1HDAC8PDK2 | |
| SCHEMBL16211604 | 0.90 | NPC1 (0.48) | MLYCDHDAC6HDAC1HDAC8HDAC3 | |
| SCHEMBL23436417 | 0.89 | NPC1 (0.48) | MLYCDHDAC6HDAC1HDAC8HDAC2 | |
| SCHEMBL16211463 | 0.89 | HDAC1 (0.59) | MLYCDHDAC6HDAC1HDAC8HDAC3 | |
| SCHEMBL17623522 | 0.87 | HDAC1 (0.49) | MLYCDHDAC6HDAC1HDAC8CYP2C19 | |
| SCHEMBL16211719 | 0.87 | HDAC6 (0.52) | MLYCDHDAC6HDAC1HDAC8HDAC11 | |
| SCHEMBL16211999 | 0.87 | HDAC1 (0.51) | MLYCDHDAC6HDAC1HDAC8HDAC3 | |
| SCHEMBL17618030 | 0.87 | ALDH1A1 (0.52) | MLYCDMEN1KMT2A | |
| SCHEMBL25980601 | 0.86 | MLYCD (0.43) | MLYCDHDAC6HDAC1HDAC8HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230248735-A1 | COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230248735-A1 | COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) | NR1H2, CFTR, CYP11B2 | MLYCD 2027/4885CYP2D6 1618/4885HDAC6 997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.